Cleveland Clinic

Self-portrait of a woman with cancer and her children

Triple-negative breast cancer vaccine shows good response in first clinical trial of patients

A drug that targets the deadliest form of breast cancer was administered to 16 women in three separate doses in a trial conducted at the Cleveland Clinic with funding from the Pentagon. The trial found that the drug elicits no side effects and triggered an immune response in 75% of patients.

Triple-negative breast cancer vaccine shows good response in first clinical trial of patients More